Correlation Between North Media and Orphazyme

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both North Media and Orphazyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining North Media and Orphazyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between North Media AS and Orphazyme AS, you can compare the effects of market volatilities on North Media and Orphazyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in North Media with a short position of Orphazyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of North Media and Orphazyme.

Diversification Opportunities for North Media and Orphazyme

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between North and Orphazyme is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding North Media AS and Orphazyme AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orphazyme AS and North Media is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on North Media AS are associated (or correlated) with Orphazyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orphazyme AS has no effect on the direction of North Media i.e., North Media and Orphazyme go up and down completely randomly.

Pair Corralation between North Media and Orphazyme

Assuming the 90 days trading horizon North Media AS is expected to under-perform the Orphazyme. But the stock apears to be less risky and, when comparing its historical volatility, North Media AS is 3.56 times less risky than Orphazyme. The stock trades about 0.0 of its potential returns per unit of risk. The Orphazyme AS is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  106,400  in Orphazyme AS on August 29, 2024 and sell it today you would lose (14,900) from holding Orphazyme AS or give up 14.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

North Media AS  vs.  Orphazyme AS

 Performance 
       Timeline  
North Media AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days North Media AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Orphazyme AS 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Orphazyme AS are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Orphazyme may actually be approaching a critical reversion point that can send shares even higher in December 2024.

North Media and Orphazyme Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with North Media and Orphazyme

The main advantage of trading using opposite North Media and Orphazyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if North Media position performs unexpectedly, Orphazyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orphazyme will offset losses from the drop in Orphazyme's long position.
The idea behind North Media AS and Orphazyme AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges